ICD-10-CM · Hip

M16.31

M16.31 identifies unilateral osteoarthritis of the right hip that developed as a direct consequence of hip dysplasia — distinct from primary or post-traumatic OA — and is fully billable for FY2026.

Verified May 8, 2026 · 6 sources ↓

Status
Billable
Chapter
13
Related CPT
6
Region
Hip
Drawn from CDCICD10DataAAPCNIHCMS

Documentation tips

What should appear in the chart to support M16.31.

Source · Editorial brief grounded in 6 cited references ↓

  • Explicitly document the causal relationship: note that the right hip OA developed as a result of hip dysplasia, not as primary or post-traumatic OA.
  • Include imaging findings that confirm both the dysplastic anatomy (e.g., lateral center-edge angle, acetabular index) and the OA changes (joint space narrowing, osteophytes, subchondral sclerosis).
  • Specify laterality as 'right hip' by name in the assessment and plan — do not rely on the imaging report alone to establish it.
  • Document conservative care history (physical therapy, activity modification, NSAIDs, intra-articular injections) to support medical necessity if THA authorization is anticipated.
  • If congenital hip dysplasia has previously been coded (Q65.xx), ensure continuity in the record connecting that history to the current degenerative diagnosis.

Related CPT procedures

Procedure codes commonly billed with M16.31. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M16.31 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

  • Using M16.11 (unilateral primary OA, right hip) when the chart documents a dysplastic etiology — these are distinct etiologic categories and incorrect code selection can cause authorization mismatches for THA.
  • Billing the non-billable parent M16.3 instead of the laterality-specific child code M16.31; most payers require the billable, specific code.
  • Failing to distinguish M16.31 (OA caused by dysplasia) from Q65.xx (congenital hip dysplasia without stated OA) — if both diagnoses are active and documented, both codes may be appropriate as dual diagnoses.
  • Assuming M16.31 applies to left-hip dysplastic OA — left hip maps to M16.32; swapping laterality creates a clinical-record mismatch that flags on audit.

Clinical context

Source · Editorial summary grounded in 6 cited references ↓

Use M16.31 when the patient's right hip osteoarthritis is attributable to underlying acetabular or hip dysplasia, not incidental degenerative wear. The dysplastic anatomy — typically shallow acetabular coverage or abnormal femoral head-neck geometry — drives eccentric loading that accelerates cartilage breakdown. The causal relationship between the dysplasia and the OA must be established by the treating clinician, not inferred from imaging alone.

This code sits under parent M16.3 (non-billable) and is the right-sided counterpart to M16.32 (left hip) and M16.2 (bilateral dysplastic OA). If laterality is undocumented or the hip affected is not specified as right, drop to M16.30 (unilateral, unspecified side) or M16.3 per payer tolerance — though specificity to M16.31 is always preferred and required for many surgical authorizations. Do not use M16.31 for primary OA of the right hip without a documented dysplastic etiology; that maps to M16.11.

M16.31 is frequently the diagnosis driving total hip arthroplasty (THA) authorization in dysplasia patients. Payers cross-reference this code against CMS LCD L36007 for lower extremity major joint replacement — failure to document the dysplastic etiology, imaging confirmation of acetabular dysplasia, and conservative care failure can trigger medical necessity denials even with a clean procedure code pairing.

Sibling codes

Other billable codes under M16.3 (laterality / anatomic variants).

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 6 cited references ↓

01What is the difference between M16.31 and M16.11?
M16.11 codes unilateral primary OA of the right hip with no specific underlying cause. M16.31 requires that the OA is directly attributable to hip dysplasia — the clinician must document that causal relationship. Using M16.11 when dysplasia is the documented etiology is a specificity error.
02Can M16.31 and a Q65 congenital dysplasia code be reported together?
Yes, if both conditions are active and documented. Q65.xx captures the structural dysplasia itself; M16.31 captures the OA that resulted from it. Report both when the clinical record supports both diagnoses being present and relevant to the encounter.
03Which CPT procedure codes most commonly pair with M16.31?
Primary THA (27130) is the most frequent surgical pairing. Revision THA (27132), hip imaging (73502, 73521), and soft-tissue procedures (27299, 27036) also commonly appear with this diagnosis. Payers validate M16.31 against LCD L36007 for THA medical necessity.
04What if the provider documents dysplasia but doesn't explicitly state it caused the OA?
The causal link must be explicit in the documentation — 'OA of the right hip secondary to hip dysplasia' or equivalent language. If only OA and dysplasia are listed without a stated relationship, default to M16.11 for the OA and add Q65.xx for the dysplasia, then query the provider to clarify the etiology before using M16.31.
05Is M16.31 appropriate for bilateral dysplastic OA affecting both hips?
No. Bilateral dysplastic OA maps to M16.2. M16.31 is strictly for unilateral involvement of the right hip. If both hips are affected, use M16.2 regardless of asymmetric severity.
06What imaging documentation best supports M16.31 for payer audit purposes?
AP pelvis and frog-leg lateral radiographs documenting reduced lateral center-edge angle, acetabular dysplasia, and concurrent OA findings (joint space narrowing below 2 mm, osteophytes, subchondral sclerosis) provide the strongest audit defense. Kellgren-Lawrence grading adds useful specificity.
07Does M16.31 require a 7th-character extension?
No. M16.31 is an M-code (musculoskeletal condition), not an injury S-code. Seventh-character extensions (A, D, S for encounter type) apply to trauma/injury codes, not to chronic disease codes in Chapter 13.

Mira AI Scribe

Mira's AI scribe captures the treating clinician's attribution of right hip OA to dysplastic anatomy, pulls laterality from the note, and flags imaging findings (lateral center-edge angle, joint space narrowing, osteophyte formation) that anchor the dysplastic etiology. This prevents downgrade to M16.11 or the non-billable M16.3, and ensures the authorization package for THA includes the correct etiologic code required under LCD L36007.

See how Mira captures M16.31 documentation

Related ICD-10 codes

Ready?

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Get started for free